These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6110835)

  • 1. Mechanism of naloxone therapy in the treatment of shock: a hypothesis.
    Dirksen R; Wood GJ; Nijhuis GM
    Lancet; 1981 Mar; 1(8220 Pt 1):607-8. PubMed ID: 6110835
    [No Abstract]   [Full Text] [Related]  

  • 2. [New perspectives in the treatment of shock. Use of naloxone].
    González-Esparza L
    Rev Med Univ Navarra; 1982 Mar; 26(1):55-8. PubMed ID: 7111954
    [No Abstract]   [Full Text] [Related]  

  • 3. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 4. Endorphins in circulatory shock.
    Napolitano L; Chernow B
    Crit Care Med; 1988 May; 16(5):566-7. PubMed ID: 3359796
    [No Abstract]   [Full Text] [Related]  

  • 5. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock.
    Reynolds DG; Gurll NJ; Vargish T; Lechner RB; Faden AI; Holaday JW
    Circ Shock; 1980; 7(1):39-48. PubMed ID: 6248265
    [No Abstract]   [Full Text] [Related]  

  • 7. Opiate antagonists: a role in the treatment of hypovolemic shock.
    Faden AI; Holaday JW
    Science; 1979 Jul; 205(4403):317-8. PubMed ID: 451606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating dopamine levels and a protective action of naloxone in canine splanchnic arterial occlusion shock.
    Eddy LJ; Joiner DW; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):113-25. PubMed ID: 6701397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Naloxone and endotoxic shock: a wonder drug?].
    Valdivielso A; Casado Flores J; Ruiz Beltrán A; García Pérez J; García-Onieva M; Hidalgo I
    An Esp Pediatr; 1984 Feb; 20(2):85-90. PubMed ID: 6712029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone in septic shock: report of two cases.
    Siram S; Park SY
    J Natl Med Assoc; 1984 Jul; 76(7):713-6. PubMed ID: 6471112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate antagonists in shock.
    Hinds CJ
    Br J Hosp Med; 1985 Oct; 34(4):233-4. PubMed ID: 4092134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone reverses the pathophysiology of shock through an antagonism of endorphin systems.
    Holaday JW; Faden AI
    Adv Biochem Psychopharmacol; 1981; 28():421-34. PubMed ID: 7211552
    [No Abstract]   [Full Text] [Related]  

  • 14. Pressor effect of naloxone in septic shock.
    Peters WP; Johnson MW; Friedman PA; Mitch WE
    Lancet; 1981 Mar; 1(8219):529-32. PubMed ID: 6111636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of shock with naloxone: a meta-analysis.
    Boeuf B; Gauvin F; Guerguerian AM; Farrell CA; Lacroix J; Jenicek M
    Crit Care Med; 1998 Nov; 26(11):1910-6. PubMed ID: 9824088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental endotoxin shock: the pathophysiologic function of endorphins and treatment with opiate antagonists.
    Faden AI; Holaday JW
    J Infect Dis; 1980 Aug; 142(2):229-38. PubMed ID: 6251139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The endogenous opioid system in shock].
    Udovichenko VI
    Patol Fiziol Eksp Ter; 1989; (6):72-7. PubMed ID: 2560827
    [No Abstract]   [Full Text] [Related]  

  • 18. Late administration of methylprednisolone does not enhance naloxone effect in hypovolemic shock.
    Beamer KC; Daly T; Vargish T
    Circ Shock; 1986; 19(2):221-30. PubMed ID: 3719922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Naloxone in the treatment and prevention of shock].
    Zou CM
    Zhonghua Nei Ke Za Zhi; 1988 Sep; 27(9):580-2. PubMed ID: 3068004
    [No Abstract]   [Full Text] [Related]  

  • 20. Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock.
    Faden AI
    JAMA; 1984 Sep; 252(9):1177-80. PubMed ID: 6088820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.